scholarly article | Q13442814 |
meta-analysis | Q815382 |
P356 | DOI | 10.1001/2012.JAMA.11374 |
P698 | PubMed publication ID | 22968891 |
P2093 | author name string | Eftychia Bika | |
Evangelia E Ntzani | |||
Evangelos C Rizos | |||
Michael S Kostapanos | |||
Moses S Elisaf | |||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | fatty acid | Q61476 |
cardiovascular disease | Q389735 | ||
systematic review | Q1504425 | ||
meta-analysis | Q815382 | ||
P304 | page(s) | 1024-1033 | |
P577 | publication date | 2012-09-01 | |
P1433 | published in | The Journal of the American Medical Association | Q1470970 |
P1476 | title | Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis | |
P478 | volume | 308 |
Q39658997 | (De-) oiling inflammasomes |
Q26747559 | 2015 Korean Guidelines for the Management of Dyslipidemia: Executive Summary (English Translation) |
Q56991525 | 2016 European Guidelines on cardiovascular disease prevention in clinical practice |
Q89490251 | 2016 European Guidelines on cardiovascular disease prevention in clinical practice : The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by repre |
Q34046881 | 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by repres |
Q35750206 | 21 days of mammalian omega-3 fatty acid supplementation improves aspects of neuromuscular function and performance in male athletes compared to olive oil placebo |
Q90439418 | 5 Conservative treatment for PAD - Risk factor management |
Q28972330 | A Comparative Overview of Prescription Omega-3 Fatty Acid Products |
Q27860879 | A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. |
Q42379898 | A double-blind randomized trial of fish oil to lower triglycerides and improve cardiometabolic risk in adolescents |
Q35675778 | A flood of health functional foods: what is to be recommended? |
Q40064587 | A healthy approach to dietary fats: understanding the science and taking action to reduce consumer confusion |
Q88564337 | A low-fat spread with added plant sterols and fish omega-3 fatty acids lowers serum triglyceride and LDL-cholesterol concentrations in individuals with modest hypercholesterolaemia and hypertriglyceridaemia |
Q37268776 | A point mutation in the human Slo1 channel that impairs its sensitivity to omega-3 docosahexaenoic acid. |
Q38167290 | Adjuvant antiarrhythmic therapy in patients with implantable cardioverter defibrillators |
Q34767372 | Advancing beyond the "heart-healthy diet" for peripheral arterial disease |
Q37289809 | Analysis of the omega-3 fatty acid content of South African fish oil supplements: a follow-up study |
Q37170684 | Anti-inflammatory effects of ω-3 polyunsaturated fatty acids and soluble epoxide hydrolase inhibitors in angiotensin-II-dependent hypertension. |
Q52879007 | Apolipoprotein E genotype status affects habitual human blood mononuclear cell gene expression and its response to fish oil intervention. |
Q37308578 | Approach to identifying and managing atherogenic dyslipidemia: a metabolic consequence of obesity and diabetes |
Q36081622 | Association of Plasma Phospholipid n-3 and n-6 Polyunsaturated Fatty Acids with Type 2 Diabetes: The EPIC-InterAct Case-Cohort Study |
Q39630777 | Association of Specific Dietary Fats With Total and Cause-Specific Mortality |
Q42629577 | Association of a Low Serum Eicosapentaenoic Acid/Arachidonic Acid Ratio with the Risk of Acute Venous Thromboembolism |
Q51075501 | Association of circulating factor seven activating protease (FSAP) and of oral Omega-3 fatty acids supplements with clinical outcome in patients with atrial fibrillation: the OMEGA-AF study. |
Q37216716 | Association of dietary omega-3 fatty acids with prevalence of metabolic syndrome: the National Heart, Lung, and Blood Institute Family Heart Study |
Q40749644 | Association of fish consumption and dietary intake of marine n-3 PUFA with myocardial infarction in a prospective Danish cohort study |
Q64097026 | Association of moderately elevated trimethylamine N-oxide with cardiovascular risk: is TMAO serving as a marker for hepatic insulin resistance |
Q48517326 | Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals. |
Q90050475 | Associations of habitual fish oil supplementation with cardiovascular outcomes and all cause mortality: evidence from a large population based cohort study |
Q37590642 | Associations of long-chain ω-3 fatty acids and fish intake with endometrial cancer risk in the VITamins And Lifestyle cohort |
Q40845482 | Associations of serum n-3 and n-6 PUFA and hair mercury with the risk of incident stroke in men: the Kuopio Ischaemic Heart Disease Risk Factor Study (KIHD). |
Q35525108 | Atherosclerosis in systemic lupus erythematosus |
Q50083483 | Bariatric surgery reduces fasting total fatty acids and increases n-3 polyunsaturated fatty acids in morbidly obese individuals. |
Q28084681 | Beneficial effects of omega-3 polyunsaturated Fatty acids in gestational diabetes: consequences in macrosomia and adulthood obesity |
Q26740486 | Benefit-Risk Assessment of Fish Oil in Preventing Cardiovascular Disease |
Q38100747 | Beyond statins: lipid management to reduce cardiovascular risk |
Q39004398 | Bioactive compounds as an alternative for drug co-therapy: Overcoming challenges in cardiovascular disease prevention |
Q38974093 | Biological and pathophysiological roles of end-products of DHA oxidation. |
Q38171245 | Biomarkers of fish oil omega-3 polyunsaturated fatty acids intake in humans |
Q90193519 | Bioprospecting for Antithrombotic Polar Lipids from Salmon, Herring, and Boarfish By-Products |
Q35642914 | Botanical oils enriched in n-6 and n-3 FADS2 products are equally effective in preventing atherosclerosis and fatty liver |
Q89570815 | Cardioprotective Effects of Omega-3 Polyunsaturated Fatty Acids: Dichotomy between Experimental and Clinical Studies |
Q53098674 | Cardioprotective effect of resveratrol analogue isorhapontigenin versus omega-3 fatty acids in isoproterenol-induced myocardial infarction in rats. |
Q40196363 | Cardioprotective effects of ω -3 PUFAs in chronic kidney disease |
Q39420208 | Cardiovascular disease prevention strategies for type 2 diabetes mellitus |
Q44579003 | Cardiovascular effects of alpha-linolenic acid--a possible role of glucagon-like peptide-1. |
Q35870114 | Changes in PTGS1 and ALOX12 Gene Expression in Peripheral Blood Mononuclear Cells Are Associated with Changes in Arachidonic Acid, Oxylipins, and Oxylipin/Fatty Acid Ratios in Response to Omega-3 Fatty Acid Supplementation |
Q28109335 | Changes in Prescription and Over-the-Counter Medication and Dietary Supplement Use Among Older Adults in the United States, 2005 vs 2011 |
Q37055557 | Changes in fish consumption in midlife and the risk of coronary heart disease in men and women |
Q36482335 | Characterization and cytotoxicity studies of the rare 21:4 n-7 acid and other polyunsaturated fatty acids from the marine opisthobranch Scaphander lignarius, isolated using bioassay guided fractionation. |
Q35650897 | Circulating B-vitamins and smoking habits are associated with serum polyunsaturated Fatty acids in patients with suspected coronary heart disease: a cross-sectional study |
Q89958688 | Circulating Fatty Acids and Risk of Coronary Heart Disease and Stroke: Individual Participant Data Meta-Analysis in Up to 16 126 Participants |
Q30415330 | Circulating and dietary omega-3 and omega-6 polyunsaturated fatty acids and incidence of CVD in the Multi-Ethnic Study of Atherosclerosis |
Q64093116 | Clinical Advances in Immunonutrition and Atherosclerosis: A Review |
Q45706448 | Clinical trials must cope better with multiplicity |
Q34411678 | Cod liver oil supplement consumption and health: cross-sectional results from the EPIC-Norfolk cohort study |
Q43121360 | Comment on: Satoh-Asahara et al. Highly purified eicosapentaenoic acid increases interleukin-10 levels of peripheral blood monocytes in obese patients with dyslipidemia. Diabetes Care 2012;35:2631-2639. |
Q64993097 | Comparison of Cardiovascular Outcomes Between Statin Monotherapy and Fish Oil and Statin Combination Therapy in a Veteran Population. |
Q46890454 | Comparison of serum fatty acid concentrations in cats with hypertrophic cardiomyopathy and healthy controls |
Q100415934 | Competitive reduction of poultry-borne enteric bacterial pathogens in chicken gut with bioactive Lactobacillus casei |
Q36846142 | Complementary and alternative medicine and cardiovascular disease: an evidence-based review |
Q92733573 | Could Omega 3 Fatty Acids Preserve Muscle Health in Rheumatoid Arthritis? |
Q60458824 | Could an El Niño event put dietary supplies of n-3 long-chain polyunsaturated fatty acids (EPA and DHA) in jeopardy |
Q38186099 | Critical review of non-statin treatments for dyslipoproteinemia. |
Q38546242 | Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer Drugs |
Q36064353 | Cytokines: roles in atherosclerosis disease progression and potential therapeutic targets |
Q61812139 | DNA methylation GrimAge strongly predicts lifespan and healthspan |
Q92678637 | DNA methylation-based estimator of telomere length |
Q26823558 | Diet and Stroke: Recent Evidence Supporting a Mediterranean-Style Diet and Food in the Primary Prevention of Stroke |
Q89365604 | Dietary Docosahexaenoic Acid Reduces Oscillatory Wall Shear Stress, Atherosclerosis, and Hypertension, Most Likely Mediated via an IL-1-Mediated Mechanism |
Q38904288 | Dietary Self-management in Heart Failure: High Tech or High Touch? |
Q36746574 | Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity: A Comprehensive Review |
Q92091772 | Dietary fats and cardiometabolic disease: mechanisms and effects on risk factors and outcomes |
Q35011156 | Dietary intake of n-3 long-chain polyunsaturated fatty acids and risk of myocardial infarction in coronary artery disease patients with or without diabetes mellitus: a prospective cohort study |
Q38726519 | Dietary management of heart failure: room for improvement? |
Q28235974 | Dietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathway |
Q35036431 | Dietary omega-3 fatty acids promote arrhythmogenic remodeling of cellular Ca2+ handling in a postinfarction model of sudden cardiac death |
Q26865717 | Dietary polyunsaturated fatty acids and inflammation: the role of phospholipid biosynthesis |
Q42721304 | Dietary supplementation with Lovaza and krill oil shortens the life span of long-lived F1 mice |
Q87771640 | Dietary supplementation with fish oil alters the expression levels of proteins governing mitochondrial dynamics and prevents high-fat diet-induced endothelial dysfunction |
Q35233185 | Dietary supplements and risk of cause-specific death, cardiovascular disease, and cancer: a protocol for a systematic review and network meta-analysis of primary prevention trials |
Q36877629 | Dietary α-Linolenic Acid, Marine ω-3 Fatty Acids, and Mortality in a Population With High Fish Consumption: Findings From the PREvención con DIeta MEDiterránea (PREDIMED) Study |
Q36432334 | Distinguishing health benefits of eicosapentaenoic and docosahexaenoic acids |
Q34102651 | Do omega-3 polyunsaturated Fatty acids prevent cardiovascular disease? A review of the randomized clinical trials |
Q56030877 | Docosahexaenoic acid supports feto-placental growth and protects cardiovascular and cognitive function: A mini review |
Q38156593 | Docosahexaenoic acid, protectin synthesis: relevance against atherothrombogenesis |
Q33901461 | Does APOE genotype modify the relations between serum lipid and erythrocyte omega-3 fatty acid levels? |
Q39255894 | Does Supplementation with Omega-3 PUFAs Add to the Prevention of Cardiovascular Disease? |
Q90641158 | Dose-response effects of omega-3 on platelet aggregation: an observational study |
Q34099690 | Double-blind randomized placebo-controlled clinical trial of omega 3 fatty acids for the treatment of diabetic patients with nonalcoholic steatohepatitis |
Q50180407 | Dyslipidaemia in the elderly: to treat or not to treat? |
Q39045120 | Dyslipidemia in patients with chronic kidney disease |
Q37496646 | ELOVL2 gene polymorphisms are associated with increases in plasma eicosapentaenoic and docosahexaenoic acid proportions after fish oil supplement |
Q91593307 | ESVM Guideline on peripheral arterial disease |
Q49353034 | Effect of Dietary Counseling on a Comprehensive Metabolic Profile from Childhood to Adulthood. |
Q53251167 | Effect of Sardina pilchardus oil on alloxan-induced diabetic rats. |
Q36721935 | Effect of Vitamin D3 on Monocyte Chemoattractant Protein 1 Production in Monocytes and Macrophages |
Q60432116 | Effect of diet on vascular health |
Q47896524 | Effect of diets rich in either saturated fat or n-6 polyunsaturated fatty acids and supplemented with long-chain n-3 polyunsaturated fatty acids on plasma lipoprotein profiles. |
Q35838579 | Effect of fish oil supplement in maintenance hemodialysis patients: a systematic review and meta-analysis of published randomized controlled trials |
Q37106424 | Effect of insulin glargine and n-3FA on carotid intima-media thickness in people with dysglycemia at high risk for cardiovascular events: the glucose reduction and atherosclerosis continuing evaluation study (ORIGIN-GRACE). |
Q42550065 | Effect of low doses of long chain n-3 polyunsaturated fatty acids on sleep-time heart rate variability: a randomized, controlled trial |
Q36232162 | Effect of omega-3 fatty acid supplementation on serum lipids and vascular inflammation in patients with end-stage renal disease: a meta-analysis |
Q55346464 | Effect of supplementation with flaxseed oil and different doses of fish oil for 2 weeks on plasma phosphatidylcholine fatty acids in young women |
Q33893037 | Effect of the amount and type of dietary fat on cardiometabolic risk factors and risk of developing type 2 diabetes, cardiovascular diseases, and cancer: a systematic review |
Q57174292 | Effectiveness of drug interventions to prevent sudden cardiac death in patients with heart failure and reduced ejection fraction: an overview of systematic reviews |
Q37589150 | Effects of a purified krill oil phospholipid rich in long-chain omega-3 fatty acids on cardiovascular disease risk factors in non-human primates with naturally occurring diabetes type-2 and dyslipidemia. |
Q59812686 | Effects of fatty and lean fish intake on stroke risk: a meta-analysis of prospective cohort studies |
Q98613050 | Effects of fish oil during hemodialysis on nutritional status and quality of life: a randomized double-blinded trial |
Q49166092 | Effects of krill oil and lean and fatty fish on cardiovascular risk markers: a randomised controlled trial. |
Q35131500 | Effects of n-3 polyunsaturated fatty acids (ω-3) supplementation on some cardiovascular risk factors with a ketogenic Mediterranean diet |
Q37704000 | Effects of omega-3 polyunsaturated Fatty acids on heart function and oxidative stress biomarkers in pediatric patients with dilated cardiomyopathy |
Q34228522 | Effects of oxidative stress on fatty acid- and one-carbon-metabolism in psychiatric and cardiovascular disease comorbidity |
Q33820362 | Effects of ω3 supplementation in elderly patients with acute myocardial infarction: design of a prospective randomized placebo controlled study |
Q34250605 | Efficacy of a unique omega-3 formulation on the correction of nutritional deficiency and its effects on cardiovascular disease risk factors in a randomized controlled VASCAZEN(®) REVEAL Trial |
Q51334679 | Emerging approaches for the treatment of hypertriglyceridemia. |
Q38263909 | Emerging drugs for hyperlipidaemia: an update |
Q38082485 | Emerging importance of omega-3 fatty acids in the innate immune response: molecular mechanisms and lipidomic strategies for their analysis |
Q28080910 | Emerging nutrition science on fatty acids and cardiovascular disease: nutritionists' perspectives |
Q36085738 | Endogenously generated omega-3 fatty acids attenuate vascular inflammation and neointimal hyperplasia by interaction with free fatty acid receptor 4 in mice |
Q92757574 | Enhancing Omega-3 Long-Chain Polyunsaturated Fatty Acid Content of Dairy-Derived Foods for Human Consumption |
Q39441530 | Enriching Diet with n-3 PUFAs to Help Prevent Cardiovascular Diseases in Healthy Adults: Results from Clinical Trials |
Q38289067 | Enriching Islet Phospholipids With Eicosapentaenoic Acid Reduces Prostaglandin E2 Signaling and Enhances Diabetic β-Cell Function. |
Q33604527 | Epigenetic changes in blood leukocytes following an omega-3 fatty acid supplementation |
Q55496344 | Erythrocyte long-chain omega-3 fatty acid levels are inversely associated with mortality and with incident cardiovascular disease: The Framingham Heart Study. |
Q34880292 | Evolving targets for lipid-modifying therapy |
Q35748105 | Experimental and computational studies of fatty acid distribution networks. |
Q36660183 | Fat chance for longevity |
Q46691449 | Fatty Acid and Lipid Profiles with Emphasis on n-3 Fatty Acids and Phospholipids from Ciona intestinalis |
Q46488015 | Façons d’identifier et de prendre en charge la dyslipidémie athérogène: Une conséquence métabolique de l’obésité et du diabète |
Q21246041 | Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction |
Q39416756 | Fish consumption and all-cause mortality in a cohort of Swedish men and women |
Q54963379 | Fish consumption, fish oil supplements and risk of atherosclerosis in the Tromsø study. |
Q37276244 | Fish intake and risks of total and cause-specific mortality in 2 population-based cohort studies of 134,296 men and women |
Q46415716 | Fish intake or omega-3 fatty acids: greater than the sum of all parts? |
Q46118317 | Fish oil (n-3 fatty acids) in drug resistant epilepsy: a randomised placebo-controlled crossover study |
Q34988645 | Fish oil and atrial fibrillation after cardiac surgery: a meta-analysis of randomized controlled trials |
Q36960923 | Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial |
Q34796255 | Fish oil and the pan-PPAR agonist tetradecylthioacetic acid affect the amino acid and carnitine metabolism in rats |
Q34752039 | Fish oil for prevention of sudden death in hemodialysis patients? |
Q38081054 | Fish oil omega-3 fatty acids and cardio-metabolic health, alone or with statins |
Q36754545 | Fish oil selectively improves heart function in a mouse model of lipid-induced cardiomyopathy |
Q40396866 | Fish oil supplementation does not lower C-reactive protein or interleukin-6 levels in healthy adults |
Q34678652 | Fish oil supplementation induces expression of genes related to cell cycle, endoplasmic reticulum stress and apoptosis in peripheral blood mononuclear cells: a transcriptomic approach |
Q60950118 | Fish, Fish Oils and Cardioprotection: Promise or Fish Tale? |
Q36019764 | Fish, omega-3 long-chain fatty acids, and all-cause mortality in a low-income US population: Results from the Southern Community Cohort Study |
Q43126586 | Fishing for answers: is oxidation of fish oil supplements a problem? |
Q28073362 | Fit with good fat? The role of n-3 polyunsaturated fatty acids on exercise performance |
Q26782788 | Food Consumption and its Impact on Cardiovascular Disease: Importance of Solutions Focused on the Globalized Food System: A Report From the Workshop Convened by the World Heart Federation |
Q42535981 | Food science and food ingredients: the need for reliable scientific approaches and correct communication, Florence, 24 March 2015. |
Q38129930 | Food security and cardioprotection: the polar lipid link |
Q33467115 | Formation of reactive aldehydes (MDA, HHE, HNE) during the digestion of cod liver oil: comparison of human and porcine in vitro digestion models |
Q52149532 | From alga to omega; have we reached peak (fish) oil? |
Q64113836 | GC-MS-Based Metabolomics to Reveal the Protective Effect of Gross Saponins of Fruit against Ischemic Stroke in Rat |
Q38809442 | Gamma-linolenic acid, Dihommo-gamma linolenic, Eicosanoids and Inflammatory Processes |
Q34212894 | Genetic predisposition scores for dyslipidaemia influence plasma lipid concentrations at baseline, but not the changes after controlled intake of n-3 polyunsaturated fatty acids. |
Q34036583 | Genetic variation in FADS1 has little effect on the association between dietary PUFA intake and cardiovascular disease. |
Q46019628 | Genome-wide association meta-analysis of fish and EPA+DHA consumption in 17 US and European cohorts. |
Q37278159 | Glycerol and fatty acids in serum predict the development of hyperglycemia and type 2 diabetes in Finnish men |
Q55286155 | Green leafy vegetables in diets with a 25:1 omega-6/omega-3 fatty acid ratio modify the erythrocyte fatty acid profile of spontaneously hypertensive rats. |
Q85744452 | Greene et al. respond |
Q89897478 | Habitual Fish Consumption, n-3 Fatty Acids, and Nuclear Magnetic Resonance Lipoprotein Subfractions in Women |
Q57056329 | Health Information Discrepancies Between Internet Media and Scientific Papers Reporting on Omega-3 Supplement Research: Comparative Analysis |
Q22241921 | Heart Disease and Stroke Statistics--2015 Update: A Report From the American Heart Association |
Q30238784 | Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association |
Q29547691 | Heart disease and stroke statistics--2014 update: a report from the American Heart Association |
Q36080332 | Heart healthy equals prostate healthy and statins, aspirin, and/or metformin (S.A.M.) are the ideal recommendations for prostate cancer prevention |
Q52778826 | High consumption of farmed salmon does not disrupt the steady state of persistent organic pollutants (POP) in human plasma and adipose tissue. |
Q37114699 | High potency fish oil supplement improves omega-3 fatty acid status in healthy adults: an open-label study using a web-based, virtual platform. |
Q34179555 | High-fat meals rich in EPA plus DHA compared with DHA only have differential effects on postprandial lipemia and plasma 8-isoprostane F2α concentrations relative to a control high-oleic acid meal: a randomized controlled trial |
Q36087812 | Higher Plasma Phospholipid n-3 PUFAs, but Lower n-6 PUFAs, Are Associated with Lower Pulse Wave Velocity among Older Adults |
Q38856659 | How reliable are randomised controlled trials for studying the relationship between diet and disease? A narrative review |
Q49592460 | Hypercholesterolaemia - practical information for non-specialists. |
Q34687470 | Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor |
Q55005204 | Identification and Quantification of Fatty Acids in T. viridissima, C. biguttulus, and C. brunneus by GC-MS. |
Q92005193 | Identification of the 12q24 locus associated with fish intake frequency by genome-wide meta-analysis in Japanese populations |
Q38099615 | Immunometabolic role of long-chain omega-3 fatty acids in obesity-induced inflammation |
Q51364877 | Impact of Adding Eicosapentaenoic Acid to Statin Therapy on Plasma Pentraxin 3 Level in Patients with Stable Coronary Artery Disease: A 6-Month, Randomized Controlled Study. |
Q57296672 | Impact of Blood or Erythrocyte Membrane Fatty Acids for Disease Risk Prediction: Focusing on Cardiovascular Disease and Chronic Kidney Disease |
Q37177415 | Impact of docosahexaenoic acid on gene expression during osteoclastogenesis in vitro--a comprehensive analysis |
Q47177161 | Impact of heterogeneity and effect size on the estimation of the optimal information size: analysis of recently published meta-analyses |
Q36419548 | Impact of methods used to express levels of circulating fatty acids on the degree and direction of associations with blood lipids in humans |
Q34142519 | Importance of fatty acid compositions in patients with peripheral arterial disease |
Q33822096 | Incremental replacement of saturated fats by n-3 fatty acids in high-fat, high-cholesterol diets reduces elevated plasma lipid levels and arterial lipoprotein lipase, macrophages and atherosclerosis in LDLR-/- mice |
Q35034713 | Individual variation in lipidomic profiles of healthy subjects in response to omega-3 Fatty acids |
Q34468355 | Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study |
Q26769891 | Inflammatory bowel disease: can omega-3 fatty acids really help? |
Q47195608 | Influence of pharmacological education on perceptions, attitudes and use of dietary supplements by medical students |
Q99573757 | Intake and metabolism of omega-3 and omega-6 polyunsaturated fatty acids: nutritional implications for cardiometabolic diseases |
Q37612576 | Intake of long-chain ω-3 fatty acids from diet and supplements in relation to mortality. |
Q39420468 | Interaction between dietary marine-derived n-3 fatty acids intake and J-point elevation on the risk of cardiac death: a 24-year follow-up of Japanese men. |
Q47792010 | Involvement of dietary Fatty acids in multiple biological and psychological functions, in morbidly obese subjects |
Q64075478 | Is Grassfed Meat and Dairy Better for Human and Environmental Health? |
Q35179684 | Is omega-3 fatty acids enriched nutrition support safe for critical ill patients? A systematic review and meta-analysis |
Q64281669 | Knowledge, attitude, and practices regarding dietary supplements in Saudi Arabia |
Q36370184 | Krill oil reduces plasma triacylglycerol level and improves related lipoprotein particle concentration, fatty acid composition and redox status in healthy young adults - a pilot study |
Q33689091 | Lifespan effects of simple and complex nutraceutical combinations fed isocalorically to mice |
Q36844453 | Lifestyle Interventions Including Nutrition, Exercise, and Supplements for Nonalcoholic Fatty Liver Disease in Children |
Q40196417 | Lifestyle recommendations for the prevention and management of metabolic syndrome: an international panel recommendation. |
Q59132881 | Linoleic Acids Overproducing Limits Growth, Survival, and Virulence of Typhimurium and Enterohaemorrhagic |
Q38222135 | Lipid-lowering therapies, glucose control and incident diabetes: evidence, mechanisms and clinical implications. |
Q35536385 | Lipidomic changes of LDL in overweight and moderately hypercholesterolemic subjects taking phytosterol- and omega-3-supplemented milk |
Q36200061 | Long chain n-3 polyunsaturated fatty acids and vascular function in patients with chronic kidney disease and healthy subjects: a cross-sectional and comparative study |
Q38151841 | Long-chain omega-3 fatty acids: time to establish a dietary reference intake |
Q58496691 | Long-chain omega-3 polyunsaturated fatty acids and risk of stroke: a meta-analysis |
Q35239530 | Long-chain ω-3 fatty acid intake and endometrial cancer risk in the Women's Health Initiative |
Q34365060 | Long-term effect of high dose omega-3 fatty acid supplementation for secondary prevention of cardiovascular outcomes: A meta-analysis of randomized, placebo controlled trials [corrected]. |
Q37620599 | Longitudinal and secular trends in dietary supplement use: Nurses' Health Study and Health Professionals Follow-Up Study, 1986-2006. |
Q42650102 | Longitudinal associations between marine omega-3 supplement users and coronary heart disease in a UK population-based cohort |
Q41636643 | Low Serum Levels of EPA are Associated with the Size and Growth Rate of Abdominal Aortic Aneurysm |
Q36963353 | Low-event-rate meta-analyses of clinical trials: implementing good practices |
Q43949640 | Macronutrients intake and risk of Parkinson's disease: A meta-analysis |
Q50099270 | Magnolol-mediated regulation of plasma triglyceride through affecting lipoprotein lipase activity in apolipoprotein A5 knock-in mice. |
Q87857921 | Management of Measurable Variable Cardiovascular Disease' Risk Factors |
Q89834651 | Marine Omega-3 (N-3) Fatty Acids for Cardiovascular Health: An Update for 2020 |
Q55044908 | Marine Omega-3 Fatty Acids, Complications of Pregnancy and Maternal Risk Factors for Offspring Cardio-Metabolic Disease. |
Q90367323 | Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants |
Q42918063 | Marine n-3 Fatty Acids and Gene Expression in Peripheral Blood Mononuclear Cells |
Q92980824 | Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer |
Q27690878 | Marine omega-3 phospholipids: metabolism and biological activities |
Q92703441 | Marine-Derived Omega-3 Polyunsaturated Fatty Acids and Heart Failure: Current Understanding for Basic to Clinical Relevance |
Q58794187 | Maternal omega-3 polyunsaturated fatty acid supplementation on offspring hip joint conformation |
Q38083007 | Medical management of stable coronary atherosclerosis. |
Q36482611 | Mercury, selenium and fish oils in marine food webs and implications for human health |
Q33601360 | Meta-analysis of oxidative stress in schizophrenia |
Q35152158 | Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts |
Q37720139 | Multiple differences between patients who initiate fish oil supplementation post-myocardial infarction and those who do not: the TRIUMPH Study. |
Q55073652 | N-3 PUFA increase bioavailability and function of endothelial progenitor cells. |
Q43628051 | N-3 fatty acids did not reduce major cardiovascular events in patients with dysglycaemia |
Q37010680 | N-3 long-chain polyunsaturated fatty acids and risk of all-cause mortality among general populations: a meta-analysis |
Q51758644 | Natural approaches in metabolic syndrome management. |
Q89260061 | Nitro-fatty acids: New drug candidates for chronic inflammatory and fibrotic diseases |
Q48749026 | No effect of n-3 fatty acids supplementation on NT-proBNP after myocardial infarction: the Alpha Omega Trial. |
Q36068816 | Nutraceutical therapies for atherosclerosis. |
Q26747475 | Nutraceuticals and Bioactive Components from Fish for Dyslipidemia and Cardiovascular Risk Reduction |
Q59810585 | Nutrient Supplement Use among the Chinese Population: A Cross-Sectional Study of the 2010⁻2012 China Nutrition and Health Surveillance |
Q28078517 | Nutrient reference value: non-communicable disease endpoints--a conference report |
Q47552947 | Nutritional Supplement and Functional Food Use Among Medical Students in India |
Q38994790 | Nutritional Supplements for the Treatment of Hypertension: A Practical Guide for Clinicians |
Q37235410 | Nutritional recommendations for cardiovascular disease prevention |
Q42447279 | Omega 3 chronic supplementation attenuates myocardial ischaemia-reperfusion injury through reinforcement of antioxidant defense system in rats. |
Q40074654 | Omega-3 Fatty Acids and Incident Ischemic Stroke and Its Atherothrombotic and Cardioembolic Subtypes in 3 US Cohorts |
Q28084892 | Omega-3 Fatty Acids and Skeletal Muscle Health |
Q37626547 | Omega-3 PUFA supplementation and the response to evoked endotoxemia in healthy volunteers |
Q30235305 | Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: A Science Advisory From the American Heart Association. |
Q26798054 | Omega-3 Polyunsaturated Fatty Acids: Structural and Functional Effects on the Vascular Wall |
Q26798057 | Omega-3 Polyunsaturated Fatty Acids: The Way Forward in Times of Mixed Evidence |
Q36287625 | Omega-3 fatty acid supplementation as an adjunctive therapy in the treatment of chronic kidney disease: a meta-analysis |
Q38930015 | Omega-3 fatty acids (ω-3 fatty acids) in epilepsy: animal models and human clinical trials |
Q85632451 | Omega-3 fatty acids and cardioprotection-IIb or not IIb? |
Q38233967 | Omega-3 fatty acids and cardiovascular disease: epidemiology and effects on cardiometabolic risk factors |
Q38160641 | Omega-3 fatty acids and cardiovascular disease: new developments and applications |
Q38736964 | Omega-3 fatty acids as an adjunct for periodontal therapy-a review |
Q28080498 | Omega-3 fatty acids for breast cancer prevention and survivorship |
Q89958068 | Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease |
Q90307768 | Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease |
Q55919856 | Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease |
Q38176274 | Omega-3 fatty acids: a growing ocean of choices |
Q38152943 | Omega-3 fatty acids: a review of the effects on adiponectin and leptin and potential implications for obesity management |
Q37571905 | Omega-3 fatty acids: mechanisms underlying 'protective effects' in atherosclerosis |
Q30409882 | Omega-3 in SLE: a double-blind, placebo-controlled randomized clinical trial of endothelial dysfunction and disease activity in systemic lupus erythematosus |
Q38083612 | Omega-3 in antiarrhythmic therapy : pros position |
Q37617749 | Omega-3 index and cardiovascular health |
Q58739768 | Omega-3 polyunsaturated fatty acid supplementation and non-alcoholic fatty liver disease: A meta-analysis of randomized controlled trials |
Q26747026 | Omega-3 polyunsaturated fatty acid supplementation in the prevention of cardiovascular disease |
Q41996741 | Omega-3 polyunsaturated fatty acids and cardiac rhythm: an introduction |
Q38260532 | Omega-3 polyunsaturated fatty acids and cardiovascular disease: an emphasis on omega-3-acid ethyl esters 90 for the treatment of hypertriglyceridemia |
Q38680756 | Omega-3 polyunsaturated fatty acids for cardiovascular diseases: present, past and future |
Q37004879 | Omega-3 polyunsaturated fatty acids increase plasma adiponectin to leptin ratio in stable coronary artery disease |
Q92633824 | Omega-3 supplement use, fish intake, and risk of non-fatal coronary artery disease and ischemic stroke in the Million Veteran Program |
Q26864908 | Omega-3 supplements and cardiovascular diseases |
Q27686781 | Omega-3s and cardiovascular health. |
Q36561806 | Over-the-counter fish oil use in a county hospital: Medication use evaluation and efficacy analysis |
Q37419411 | Overview of omega-3 Fatty Acid therapies |
Q21284850 | Oxidation of marine omega-3 supplements and human health |
Q49377009 | PM2.5 inhalation induces intracranial atherosclerosis which may be ameliorated by omega 3 fatty acids. |
Q37206674 | PURLs: should you still recommend omega-3 supplements? |
Q52369219 | Paradigm shift - Metabolic transformation of docosahexaenoic and eicosapentaenoic acids to bioactives exemplify the promise of fatty acid drug discovery. |
Q38191066 | Pharmacotherapy to reduce arrhythmic mortality |
Q47840702 | Phospholipids of Animal and Marine Origin: Structure, Function, and Anti-Inflammatory Properties. |
Q59390185 | Pitfalls in the use of randomised controlled trials for fish oil studies with cardiac patients |
Q50077478 | Plasma n-3 and n-6 Fatty Acids Are Differentially Related to Carotid Plaque and Its Progression: The Multi-Ethnic Study of Atherosclerosis. |
Q24633239 | Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial |
Q36974431 | Plasma phospholipid long-chain ω-3 fatty acids and total and cause-specific mortality in older adults: a cohort study |
Q57806953 | Polyunsaturated Fatty Acids and Their Potential Therapeutic Role in Cardiovascular System Disorders-A Review |
Q36926384 | Polyunsaturated fatty acids in serum and homocysteine concentrations in Japanese men and women: a cross-sectional study |
Q58804123 | Polyunsaturated fatty acids supplementation impairs anti-oxidant high-density lipoprotein function in heart failure |
Q38460480 | Postprandial Dysmetabolism and Oxidative Stress in Type 2 Diabetes: Pathogenetic Mechanisms and Therapeutic Strategies |
Q39076677 | Prenatal Docosahexaenoic Acid Supplementation Does Not Affect Nonfasting Serum Lipid and Glucose Concentrations of Offspring at 4 Years of Age in a Follow-Up of a Randomized Controlled Clinical Trial in Mexico. |
Q33845330 | Press releases issued by supplements industry organisations and non-industry organisations in response to publication of clinical research findings: a case-control study. |
Q38856700 | Prevalence of Glucosamine and Omega-3 Fatty Acid Use and Characteristics of Users among Mid-Age Women: Analysis of a Nationally Representative Sample of 10,638 Women |
Q26822760 | Prevention and management of type 2 diabetes: dietary components and nutritional strategies |
Q90467118 | Prevention of Cardiovascular Events with Omega-3 Polyunsaturated Fatty Acids and the Mechanism Involved |
Q38644827 | Principles in the Evaluation of Systematic Reviews |
Q38168873 | Protective effects of dietary PUFA against chronic disease: evidence from epidemiological studies and intervention trials. |
Q26851781 | Public Health Perspectives on Aquaculture |
Q35151307 | Pulmonary delivery of docosahexaenoic acid mitigates bleomycin-induced pulmonary fibrosis |
Q34536800 | Recent findings on the health effects of omega-3 fatty acids and statins, and their interactions: do statins inhibit omega-3? |
Q36355384 | Reduction of heart rate by omega-3 fatty acids and the potential underlying mechanisms |
Q38899898 | Regulation of inflammation by lipid mediators in oral diseases |
Q26996039 | Residual macrovascular risk in 2013: what have we learned? |
Q45064553 | Resolution of vascular injury: Specialized lipid mediators and their evolving therapeutic implications |
Q47633216 | Review of Cardiometabolic Effects of Prescription Omega-3 Fatty Acids |
Q24564203 | Role of Glitazars in atherogenic dyslipidemia and diabetes: Two birds with one stone? |
Q90283300 | Role of Oleic Acid in the Gut-Liver Axis: From Diet to the Regulation of Its Synthesis via Stearoyl-CoA Desaturase 1 (SCD1) |
Q38353525 | Role of fish oil in human health and possible mechanism to reduce the inflammation |
Q38116485 | Role of omega-3 fatty acids in obesity, metabolic syndrome, and cardiovascular diseases: a review of the evidence. |
Q93120785 | Rounding the corner on residual risk: Implications of REDUCE-IT for omega-3 polyunsaturated fatty acids treatment in secondary prevention of atherosclerotic cardiovascular disease |
Q26799530 | Saturated Fats Versus Polyunsaturated Fats Versus Carbohydrates for Cardiovascular Disease Prevention and Treatment |
Q38379544 | Saturated Fats and Cardiovascular Disease: Interpretations Not as Simple as They Once Were |
Q33856033 | Saturated Fatty Acids and Cardiovascular Disease: Replacements for Saturated Fat to Reduce Cardiovascular Risk. |
Q47154740 | Scientific Opinion on health benefits of seafood (fish and shellfish) consumption in relation to health risks associated with exposure to methylmercury |
Q33698614 | Selection in Europeans on Fatty Acid Desaturases Associated with Dietary Changes |
Q36412184 | Serum lipid profiles, the prevalence of dyslipidemia and the risk factors in two isolated Chinese minorities |
Q55499401 | Sex Differences in Omega-3 and -6 Fatty Acids and Health Status Among Young Adults With Acute Myocardial Infarction: Results From the VIRGO Study. |
Q38903226 | Short Chain and Polyunsaturated Fatty Acids in Host Gut Health and Foodborne Bacterial Pathogen Inhibition. |
Q36141602 | Short-Term, High-Dose Fish Oil Supplementation Increases the Production of Omega-3 Fatty Acid-Derived Mediators in Patients With Peripheral Artery Disease (the OMEGA-PAD I Trial) |
Q42629565 | Significance of Serum Polyunsaturated Fatty Acid Level Imbalance in Patients with Acute Venous Thromboembolism |
Q41158349 | Significance of long chain polyunsaturated fatty acids in human health. |
Q28304230 | Stabilized epoxygenated fatty acids regulate inflammation, pain, angiogenesis and cancer |
Q38881156 | Statin combination therapy and cardiovascular risk reduction |
Q38338721 | Strategic nutrition: a vision for the twenty-first century |
Q55470328 | Structural Elucidation of Irish Organic Farmed Salmon (Salmo salar) Polar Lipids with Antithrombotic Activities. |
Q89749602 | Supplemental Vitamins and Minerals for Cardiovascular Disease Prevention and Treatment |
Q91654760 | Synergistic anti-atherosclerotic role of combined treatment of omega-3 and co-enzyme Q10 in hypercholesterolemia-induced obese rats |
Q38904497 | Targeting ApoC-III to Reduce Coronary Disease Risk |
Q33586632 | The 2015 Dutch food-based dietary guidelines |
Q26781534 | The Current Role of Omega-3 Fatty Acids in the Management of Atrial Fibrillation |
Q58571873 | The Effects of Omega-3 and Vitamin E Co-supplementation on Carotid Intima-media Thickness and Inflammatory Factors in Patients with Polycystic Ovary Syndrome |
Q57475802 | The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk |
Q92255416 | The Mediterranean Diet Slows Down the Progression of Aging and Helps to Prevent the Onset of Frailty: A Narrative Review |
Q37142034 | The PBMC transcriptome profile after intake of oxidized versus high-quality fish oil: an explorative study in healthy subjects |
Q53480627 | The Ratio of Eicosapentaenoic Acid (EPA) to Arachidonic Acid may be a Residual Risk Marker in Stable Coronary Artery Disease Patients Receiving Treatment with Statin Following EPA Therapy. |
Q48943429 | The Role of Omega-3 Fatty Acids in Diets. |
Q55515152 | The Role of n-3 Long Chain Polyunsaturated Fatty Acids in Cardiovascular Disease Prevention, and Interactions with Statins. |
Q90247594 | The Supportive Treatment of IgA Nephropathy and Idiopathic Nephrotic Syndrome: How Useful are Omega-3 Polyunsaturated Fatty Acids? |
Q35848011 | The association between dietary omega-3 fatty acids and cardiovascular death: the Singapore Chinese Health Study |
Q35817077 | The association between marine n-3 polyunsaturated fatty acid levels and survival after renal transplantation. |
Q38419205 | The autonomic nervous system and cardiovascular disease: role of n-3 PUFAs |
Q47598211 | The cardiovascular benefits of indiscriminate supplementation of omega-3 fatty acids; meta-analysis and decision-making approach |
Q35395358 | The effects of aspirin on platelet function and lysophosphatidic acids depend on plasma concentrations of EPA and DHA. |
Q26822900 | The failure of cancer chemoprevention |
Q38683354 | The future for long chain n-3 PUFA in the prevention of coronary heart disease: do we need to target non-fish-eaters? |
Q38928300 | The impact of fatty acid desaturase genotype on fatty acid status and cardiovascular health in adults |
Q26852020 | The impact of omega-3 polyunsaturated fatty acid supplementation on the incidence of cardiovascular events and complications in peripheral arterial disease: a systematic review and meta-analysis |
Q64912251 | The injured brain might need more fat! |
Q87209329 | The percentage of DHA in erythrocytes can detect non-adherence to advice to increase EPA and DHA intakes |
Q34359967 | The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management |
Q36261660 | The ratio of serum n-3 to n-6 polyunsaturated fatty acids is associated with diabetes mellitus in patients with prior myocardial infarction: a multicenter cross-sectional study |
Q41675416 | The relation of red blood cell fatty acids with vascular stiffness, cardiac structure and left ventricular function: the Framingham Heart Study |
Q36495874 | The role of long-chained marine N-3 polyunsaturated Fatty acids in cardiovascular disease. |
Q38185266 | The role of n - 6 and n - 3 polyunsaturated fatty acids in the manifestation of the metabolic syndrome in cardiovascular disease and non-alcoholic fatty liver disease |
Q26830164 | The year in atherothrombosis |
Q43123138 | Trans fatty acid isomers in mortality and incident coronary heart disease risk |
Q37510091 | Treadmill exercise promotes neuroprotection against cerebral ischemia-reperfusion injury via downregulation of pro-inflammatory mediators |
Q38553332 | Treatment options for dyslipidemia in chronic kidney disease and for protection from contrast-induced nephropathy |
Q47358362 | Trends in botanical dietary supplement use among US adults by cancer status: The National Health and Nutrition Examination Survey, 1999 to 2014. |
Q41104057 | Two Decades of Cardiovascular Trials With Primary Surrogate Endpoints: 1990-2011. |
Q36143171 | Update on the Vitamin D and OmegA-3 trial (VITAL). |
Q34961885 | Updated guidelines for the management of dyslipidemia and prevention of cardiovascular disease by pharmacists. |
Q30587127 | Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis |
Q48257266 | Variability in the cardiometabolic effects of ω-3 long-chain PUFAs: background diet, timing, and genetics |
Q47642249 | Very long-chain n-3 fatty acids and human health: fact, fiction and the future |
Q26796303 | Vitamin E function and requirements in relation to PUFA |
Q37557154 | Why fish oil fails: a comprehensive 21st century lipids-based physiologic analysis |
Q88007987 | [On the overestimation of the benefit of prevention] |
Q52838993 | [Severe hypertriglyceridemia : Diagnostics and new treatment principles]. |
Q50075478 | [Therapeutic options in hyperlipidemia]. |
Q92146832 | n-3 Fatty acids and risk for fatal coronary disease |
Q51312635 | n-3 PUFA esterified to glycerol or as ethyl esters reduce non-fasting plasma triacylglycerol in subjects with hypertriglyceridemia: a randomized trial. |
Q47396742 | n-3 Polyunsaturated Fatty Acids and Cardiovascular Disease: Principles, Practices, Pitfalls, and Promises; A Contemporary Review. |
Q38174039 | n-3 Polyunsaturated fatty acids modulate metabolism of insulin-sensitive tissues: implication for the prevention of type 2 diabetes |
Q33819705 | n-3 Polyunsaturated fatty acids supplementation in peripheral artery disease: the OMEGA-PAD trial. |
Q38119178 | n-3 fatty acids and cardiovascular disease: the story is not over yet. |
Q36809876 | {Omega}-3 fatty acid supplement use in the 45 and Up Study Cohort |
Q26782277 | ω-3 Fatty Acids and Cardiovascular Diseases: Effects, Mechanisms and Dietary Relevance |
Q39644797 | ω-3 Polyunsaturated Fatty Acid Biomarkers and Coronary Heart Disease: Pooling Project of 19 Cohort Studies |
Q44487661 | ω-3 fatty acids, atherosclerosis progression and cardiovascular outcomes in recent trials: new pieces in a complex puzzle. |
Q39041784 | ω3-Polyunsaturated fatty acids for heart failure: Effects of dose on efficacy and novel signaling through free fatty acid receptor 4. |
Search more.